What You Should Know:
- Medly Pharmacy raises $100M investment co-led by
Volition Capital and Greycroft to propel Medly's leadership in the $500B+
digital on-demand pharmacy market.
- Medly will use the funding to expand its digital on-demand pharmacy platform, enter new markets, and provide category-leading services to patients and partners across the country that is well-positioned to meet new customer needs.
Medly Pharmacy (Medly), an industry-leading full-service digital
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Noteworth Lands $5M to Expand All-in-One Care Delivery Platform
What You Should Know:
- Noteworth, a first-of-its-kind Digital Healthcare
platform for modernizing Digital Medicine delivery operations, secured a $5
million oversubscribed seed funding round led by Laconia Capital Group
- With this investment, the company will continue to
build upon the delivery of Noteworth’s first-of-its-kind Digital Healthcare
platform.
Noteworth,
a Hoboken, NJ-based all-in-one-care delivery platform for modernizing digital medicine
delivery
Read More
HHS Taps Fenway Health as Pilot Site for Precision Medicine Project
What You Should Know:
- Fenway
Health has been selected as the pilot site to participate in the Advancing
Standards for Precision Medicine (ASPM) project.
- The ASPM project
is focused on how healthcare providers can systematically identify the
socio-economic factors that may impact the health of patients in order to
provide more individualized care that reflects patients’ needs.
Fenway Health, a
Boston, MA-based Federally Qualified Community Health Center (FQCHC)
Read More
Socialized Medicine Shows its Strengths During COVID-19 – But Only When Paired with Tech
What the US and other
countries can learn from the “Taiwan Example”
Italy has a single-payer medical system, yet it didn’t spare the country from COVID-19. On the contrary, Italy was among the hardest hit and is still struggling. That’s a common talking point one might hear from certain US-based pundits who are critical of so-called “socialized medicine.”
According to international healthcare insurance provider Allianz
Care, “The healthcare system in Italy is a regionally based
Read More
UnitedHealth Group Launches New Digital Health Therapy for Type 2 Diabetes
What You Should Know:
- UnitedHealth Group launches a new pilot for digital health therapy for Type 2 Diabetes to nearly a quarter-million members at no additional cost to more than 230,000 employer-sponsored, fully insured UnitedHealthcare members in 27 states and Washington, D.C.
- The therapy, known as Level2, helps participants gain
real-time insights about their condition and, for some, successfully reduces
spikes in blood sugar levels or achieves Type 2 Diabetes remission.
- The
Read More
Paige Lands Additional $20M for AI-Native Digital Pathology Ecosystem
What You Should Know:
- Paige secures an additional $15M from Goldman Sachs totaling $20M to close out a total Series B funding round of $70M for its AI-native digital pathology ecosystem.
- The company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment.
Paige, an NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it received an additional $15M from
Read More
COVID-19 Has Permanently Shifted Patient Behavior Towards Virtual Care
What You Should Know:
- The COVID-19 crisis has significantly impacted the
patient care paradigm, and the ripple effects have altered patient behaviors
and expectations, requiring a significant change in how life sciences companies
engage with and support patients
- Accenture surveyed 2700 patients about changes in care
during COVID-19 and found a major shift to virtual care, which patients
embraced.
- Virtual care is here to stay and can be an integral
part of the patient experience
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
New CVS Pharmacy App Feature Can Read Prescription Labels Out Loud for Visually Impaired
What You Should Know:
- CVS introduced Spoken Rx™, a new feature of the
CVS Pharmacy app that can read important prescription information out loud. It
is vitally important for patient safety and adherence that prescription labels
are clear and visible, but for patients with visual impairments or those who
can’t read standard print labels, that’s not always the case.
- Spoken Rx provides an audible label option that reads
important info such as patient name, medication name,
Read More
Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring
What You Should Know:
- Philips integrates the BioIntelliSense FDA-cleared
BioSticker™ sensor as part of its remote patient monitoring solutions for
patients outside the hospital.
- Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms, including COVID-19.
- Healthcare Highways is the first to leverage the BioSticker sensor as a part of Philips’ RPM program in the U.S.
Philips,
Read More
